Inventor · disambiguated record
Micheal Gaul
Also filed as: GAUL MICHEAL · GAUL MICHEAL D
22 granted patents·7 pending applications·21 citations·filing 2005–2024
91Inventor score
Top patents by PatentIndex Score
29 records- 0182US10214493B2Indazole derivatives useful as glucagon receptor antagonistsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Feb 26, 2019·3 cites·13 claims
- 0280US10000473B2Indazole derivatives useful as glucagon receptor antagonistsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Jun 19, 2018·3 cites·20 claims
- 0379US7622579B2Hetero isonipecotic modulators of vanilloid VR1 receptorJANSSEN PHARMACEUTICA NV·Filed 2005·Granted Nov 24, 2009·3 cites·14 claims
- 0476US8445690B2Aminothiazolones as estrogen related receptor-alpha modulatorsBIGNAN GILLES·Filed 2011·Granted May 21, 2013·4 cites·23 claims
- 0575US8263781B2Substituted aminothiazolone indazoles as estrogen related receptor-alpha modulatorsBIGNAN GILLES·Filed 2010·Granted Sep 11, 2012·3 cites·22 claims
- 0673US8796256B2Substituted thiazolidinedione indazoles, indoles and benzotriazoles as estrogen-related receptor-α modulatorsBIGNAN GILLES·Filed 2011·Granted Aug 5, 2014·3 cites·28 claims
- 0773US2024228465A1Substituted pyridine n-oxide derivatives useful as a factor xia inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2024·Application pending·0 cites
- 0869US11098016B2Indazole derivatives useful as glucagon receptor antagonistsJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Aug 24, 2021·0 cites·12 claims
- 0967US11919881B2Substituted pyridine N-oxide derivatives useful as a factor XIa inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2022·Granted Mar 5, 2024·0 cites·9 claims
- 1067US11014917B25-fluoro-c-(aryl or heterocyclyl)-glycoside derivatives useful as dual SGLT1 / SGLT2 modulatorsJANSSEN PHARMACEUTICA NV·Filed 2020·Granted May 25, 2021·0 cites·7 claims
- 1167US8399681B2Substituted aminothiazolone indazoles as estrogen related receptor-alpha modulatorsBIGNAN GILLES·Filed 2012·Granted Mar 19, 2013·1 cites·14 claims
- 1266US8426604B2Aminothiazolones as estrogen related receptor-alpha modulatorsBIGNAN GILLES·Filed 2011·Granted Apr 23, 2013·1 cites·23 claims
- 1362US2023295157A13-(1h-imidazol-2-yl)-2,3,8,8a-tetrahydroindolizin-5(1h)-one derivatives useful as factor xia inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2021·Application pending·0 cites
- 1461US11897880B27,8-dihydrobenzo[e]pyrido[3,4-c]azocine-2,5(3H,6H)-dione derivatives useful as a factor XIa inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2022·Granted Feb 13, 2024·0 cites·11 claims
- 1559US11845748B2Bicyclic pyridine N-oxide derivatives useful as a factor XIa inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2022·Granted Dec 19, 2023·0 cites·10 claims
- 1659US10774048B2Indazole derivatives useful as glucagon receptor antagonistsJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Sep 15, 2020·0 cites·10 claims
- 1759US10696662B25-fluoro-C-(aryl or heterocyclyl)-glycoside derivatives useful as dual SGLT1 / SGLT2 modulatorsJANSSEN PHARMACEUTICA NV·Filed 2018·Granted Jun 30, 2020·0 cites·19 claims
- 1859US2023183233A1Bicyclic Pyridin-2-one and pyrimidin-4-one Derivatives Useful As a Factor XIa InhibitorsJANSSEN PHARMACEUTICA NV·Filed 2022·Application pending·0 cites
- 1958US8604190B2Hetero isonipecotic modulators of vanilloid VR1 receptorGAUL MICHEAL D·Filed 2009·Granted Dec 10, 2013·0 cites·11 claims
- 2058US2023097157A1Bicyclic Pyridin-2-one and pyrimidin-4-one Derivatives Useful As a Factor XIa InhibitorsJANSSEN PHARMACEUTICA NV·Filed 2022·Application pending·0 cites
- 2155US11814364B2Pyridine N-oxide derivatives useful as factor XIa inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2022·Granted Nov 14, 2023·0 cites·10 claims
- 2255US2022009906A1Isoindolin-1-one derivatives useful as grk2 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2021·Application pending·0 cites
- 2351US2022242850A1Phthalazin-1-one derivatives useful as grk2 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2020·Application pending·0 cites
- 2450US2022267298A1Quinazolin-4-one derivatives useful as grk2 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2020·Application pending·0 cites
- 2545US9012412B2Dual SGLT1/SGLT2 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Apr 21, 2015·0 cites·20 claims
- 2644US9238658B2Substituted piperidinyl-carboxamide derivatives useful as SCD 1 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2012·Granted Jan 19, 2016·0 cites·13 claims
- 2742US9102669B2Substituted piperidinyl-pyridazinyl derivatives useful as SCD 1 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2012·Granted Aug 11, 2015·0 cites·13 claims
- 2841US10815210B2Benzocyclobutane derivatives useful as dual SGLT1 / SGLT2 modulatorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Oct 27, 2020·0 cites·14 claims
- 2941US10251864B2Indole derivatives useful as glucagon receptor antagonistsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Apr 9, 2019·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when Micheal Gaul files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →